Clinical Trial Update: Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial is evaluating stereotactic boost and short-course radiation therapy for oropharyngeal cancer and is currently recruiting at CHUM.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Head and Neck Cancer, Oropharynx Cancer | Phase 3 | Status: RECRUITING